Should You Buy Adaptive Biotechnologies Corp (ADPT) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast ADPT stock price to rise
8 Analyst Rating
Wall Street analysts forecast ADPT stock price to rise
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 15.190
Low
20
Averages
20.86
High
22
Current: 15.190
Low
20
Averages
20.86
High
22
Morgan Stanley
Kallum Titchmarsh
Equal Weight
downgrade
$21 -> $18
AI Analysis
2026-05-12
Reason
Morgan Stanley
Kallum Titchmarsh
Price Target
$21 -> $18
AI Analysis
2026-05-12
downgrade
Equal Weight
Reason
Morgan Stanley analyst Kallum Titchmarsh lowered the firm's price target on Adaptive Biotechnologies to $18 from $21 and keeps an Equal Weight rating on the shares.
JPMorgan
Overweight
downgrade
$21 -> $19
2026-05-06
Reason
JPMorgan
Price Target
$21 -> $19
2026-05-06
downgrade
Overweight
Reason
JPMorgan lowered the firm's price target on Adaptive Biotechnologies to $19 from $21 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q1 report.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ADPT
